PLNTQ yields 2000000.00% · PFE yields 6.13%● Live data
📍 PLNTQ pulled ahead of the other in Year 1
Combined, PLNTQ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PLNTQ + PFE for your $10,000?
Proliance International, Inc. designs, manufactures, and markets heat exchange products and temperature control parts for the automotive and light truck aftermarket, as well as heat exchange products. The company's heat exchange products include radiators, heater cores, heaters, radiator cores, and condensers; and temperature control parts comprise condensers, compressors, accumulators/driers, and evaporators. It also offers air conditioning parts and supplies, such as hose and tube assemblies, expansion valves, blowers, and fan clutches. In addition, the company provides charge air coolers, oil coolers, marine coolers, and other specialty heat exchangers for heavy-duty trucks, buses, specialty equipment, and industrial and marine applications, such as agricultural, construction and military vehicles, oil rigs, stationary power generation equipment, and inland sea-going vessels. Its customers include national retailers of aftermarket automotive products, warehouse distributors, radiator shops, hard parts jobbers, and other manufacturers. The company offers its products in the United States, Canada, Mexico, Europe, and Central America. Proliance International, Inc. was formerly known as Transpro, Inc. and changed its name to Proliance International, Inc. in July 2005. The company was founded in 1915 and is based in New Haven, Connecticut.
Full PLNTQ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.